New indications for exenatide therapy of type 2 diabetes mellitus

QR Code

New indications for exenatide therapy of type 2 diabetes mellitus

Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus(DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct hyperglycemia but also reduce body weight. Exenatid...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova
Format:	article
Langue:	EN RU
Publié:	Endocrinology Research Centre 2010
Sujets:	type 2 diabetes mellitus obesity incretin mimetics exenatide byetta Nutritional diseases. Deficiency diseases RC620-627
Accès en ligne:	https://doaj.org/article/966c47654fdf45d8a1986ff7d62d681c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
par: Alexander Sergeevich Ametov, et autres
Publié: (2011)

Ion- and osmoregulating renal functions in patients with type 2 diabetes mellitus
par: Evgeniya Vladimirovna Balbotkina, et autres
Publié: (2016)

New prospects in the treatment of diabetes mellitus
par: Minara Shamkhalovna Shamkhalova, et autres
Publié: (2012)

Glibenclamide therapy: pros and cons
par: Olga Konstantinovna Vikulova, et autres
Publié: (2011)

Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
par: Minara Shamkhalovna Shamkhalova, et autres
Publié: (2012)

National register of diabetes mellitus in Russian Federation.
par: Ivan Ivanovich Dedov, et autres
Publié: (2015)

The results of open observational trial DIAMOND
par: Marina Vladimirovna Shestakova, et autres
Publié: (2011)

Type 2 diabetes mellitus: time to change the concept
par: Shmuel Levit, et autres
Publié: (2013)

Obesity - a risk factor of renal pathology in patients with type 2 diabetes mellitus
par: Svetlana Alekseevna Savel'eva, et autres
Publié: (2010)

Ileal transposition in surgical treatment for type 2 diabetes mellitus
par: Oleg Viktorovich Kornyushin, et autres
Publié: (2015)

Renal allograft nephropathy in patient with type 1 diabetes mellitus
par: Ekaterina Vladimirovna Ivannikova, et autres
Publié: (2012)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
par: Seewoodhary J, et autres
Publié: (2010)

Pathogenetic significance of single nucleotide polymorphisms in the gastric inhibitory polypeptide receptor gene for the development of carbohydrate metabolism disorders in obesity
par: Daria S. Skuratovskaia, et autres
Publié: (2016)

Epidemiology of diabetes mellitus in Russian Federation: clinical and statistical report according to the federal diabetes registry
par: Ivan Ivanovich Dedov, et autres
Publié: (2017)

Vildagliptin and its role in the treatment of diabetes mellitus
par: Yury Shavkatovich Khalimov
Publié: (2010)

Pre-clinical markers for diagnosis of diabetic nephropathy in patients with type 1 diabetes mellitus
par: Nadezhda Olegovna Lebedeva, et autres
Publié: (2012)

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
par: Nina A. Petunina, et autres
Publié: (2018)

New glance at pathogenesis of type 2 diabetes mellitus: incretin and antiincretin systems.
par: Ekaterina Alekseevna Shestakova
Publié: (2011)

Comments on the Consensus statement of the American Diabetes Association and the European Association for the Studyof Diabetes on the medical management of hyperglycemia in type 2 diabetes
par: Ivan Ivanovich Dedov, et autres
Publié: (2009)

The 3d World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension, Prague, 13-16 May 2010
par: Olga Konstantinovna Vikulova, et autres
Publié: (2010)

Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
par: Olga Yuryevna Sukhareva, et autres
Publié: (2016)

Glucagon and alpha-cells as a novel therapeutic target in the management of diabetes mellitus
par: Nina Alexandrovna Petunina, et autres
Publié: (2013)

The dynamics of the main epidemiological indicators among living in Moscow patients with diabetes mellitus (2013–2018)
par: Mikhail B. Antsiferov, et autres
Publié: (2020)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
par: Alexander Sergeevich Ametov, et autres
Publié: (2011)

Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
par: Olga Konstantinovna Vikulova
Publié: (2012)

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
par: Marina Vladimirovna Shestakova
Publié: (2010)

Diabetes mellitus and chronic kidney disease: achievements, unresolved problems, and prospects for therapy
par: Marina Vladimirovna Shestakova, et autres
Publié: (2011)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
par: Alexander Sergeevich Ametov, et autres
Publié: (2010)

Prevalence of renal lesions in patients with type 1 and 2 diabetes mellitus in the Russian Federation
par: Oksana Vladimirovna Maslova, et autres
Publié: (2009)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
par: Marina Vladimirovna Shestakova
Publié: (2010)

Possibilities of metabolic surgery for the treatment of type 2 diabetes mellitus in patients with grade 1 alimentary obesity
par: Vladimir V. Salukhov, et autres
Publié: (2018)

The role of the tissue renin-angiotensin-aldosterone system in the development of metabolic syndrome, diabetes mellitus and itsvascular complications
par: Marina Vladimirovna Shestakova
Publié: (2010)

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
par: Elena Valer'evna Biryukova
Publié: (2014)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
par: Ivona Renata Yarek-Martynova, et autres
Publié: (2011)

Standards of Medical Care in Diabetes-2009 (American Diabetes Association): executive summary
par: Olga Konstantinovna Vikulova
Publié: (2009)

Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity
par: E. V. Pokrovskaya, et autres
Publié: (2021)

Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs
par: Olga D. Ostroumova, et autres
Publié: (2018)

Diabetes mellitus type 2: a new indication for hypercortisolism screening?
par: Natalya Ivanovna Volkova, et autres
Publié: (2012)

Pharmacoeconomic assessment of type 2 diabetes mellitus care on the base of Endocrinology Research Centre, Moscow
par: Ivan Ivanovich Dedov, et autres
Publié: (2012)

Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
par: Marina Vladimirovna Shestakova, et autres
Publié: (2016)